Evidence map›Paper›PMID 37627679›Full record

ReviewAntibiotics (Basel, Switzerland)2023

Biofilm of

Yasmine Elshenawi, Shuai Hu, Skander Hathroubi

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Advances in the Management of RefractoryGastro hep advances · 2026
    Review
  7. Review
  8. Article
  9. CoccoidVirulence · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Monoterpene Indole Alkaloids with Antimicrobial Activity AgainstInternational journal of molecular sciences · 2025
    Article
  14. Article
  15. Towards EffectiveInternational journal of molecular sciences · 2025
    Review
  16. Article
  17. Medicina (Kaunas, Lithuania) · 2025
    Review
  18. TargetingFrontiers in cellular and infection microbiology · 2025
    Article
  19. Frontiers in immunology · 2025
    Article
  20. Nine-year risk stratification and prediction ofFrontiers in public health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yasmine ElshenawiDepartment of Microbiology and Environmental Toxicology, University of California, Santa Cruz, CA 95064, USA.
Shuai HuDepartment of Microbiology and Environmental Toxicology, University of California, Santa Cruz, CA 95064, USA.
Skander HathroubiSpartha Medical, CRBS 1 Rue Eugène Boeckel, 67000 Strasbourg, France.ORCID 0000-0002-5917-2785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

abiotic/biotic adhesionanti-biofilm strategiesantibiotic resistancebiofilmsclinical treatment strategiesdispersionextra polymeric substanceHelicobacter pyloriplanktonic

Identifiers

PMID37627679
PMCPMC10451559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.